Jonathan I Lieber's Net Worth

$216 Thousand

Estimate Recalculated May 15, 2024 07:20PM EST

Who is Jonathan I Lieber?

Jonathan I Lieber does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include REPLIGEN CORP, Altus Pharmaceuticals Inc., HISTOGENICS CORP, Rallybio Corp, Salarius Pharmaceuticals, Inc., Checkmate Pharmaceuticals, Inc., and APPLIED GENETIC TECHNOLOGIES CORP.

SEC CIK

Jonathan I Lieber's CIK is 0001350090

Past Insider Trading and Trends

2007 was Jonathan I Lieber's most active year for acquiring shares with 10 total transactions. Jonathan I Lieber's most active month to acquire stocks was the month of January. 2007 was Jonathan I Lieber's most active year for disposing of shares, totalling 16 transactions. Jonathan I Lieber's most active month to dispose stocks was the month of September. 2007 saw Jonathan I Lieber paying a total of $86,240.00 for 75,500 shares, this is the most they've acquired in one year. In 2007 Jonathan I Lieber cashed out on 44,000 shares for a total of $271,092.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

REPLIGEN CORP (RGEN) Snapshot price: $200.52

CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 28
Form 3
—
0
—
—
0
No matching records found

Altus Pharmaceuticals Inc. No price found

SVP, CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
$6.98
-$10,998.00
0
Scheduled
Dec 17
Form 4
—
0
$7.64
-$13,374.00
0
Scheduled
Nov 15
Form 4
—
0
$7.69
-$13,572.00
0
Scheduled
Oct 15
Form 4
—
0
$7.10
-$11,430.00
0
Scheduled
Sep 17
Form 4
—
0
$7.17
-$58,500.00
0
Scheduled
Aug 15
Form 4
—
0
$9.07
-$18,558.00
0
Scheduled
Mar 15
Form 4
—
0
—
—
0
Mar 4
Form 4
—
0
$10.86
-$27,780.00
0
Scheduled
Feb 15
Form 4
—
0
$11.58
-$30,640.00
0
Scheduled
Jan 16
Form 4
—
0
$11.83
-$31,640.00
0
Scheduled
Dec 15
Form 4
—
0
$11.27
-$29,380.00
0
Scheduled
Nov 15
Form 3
—
0
—
—
0
No matching records found

HISTOGENICS CORP (OCGN) Snapshot price: $0.5183

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Feb 14
Form 4
∞
5K
$1.95
$9,730.50
5K
Dec 2
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
—
—
0
Jul 2
Form 3
—
0
—
—
0
No matching records found

Rallybio Corp (RLYB) Snapshot price: $1.67

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 15
Form 4
∞
5K
$5.21
$26,050.00
5K
Mar 14
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found

Salarius Pharmaceuticals, Inc. (SLRX) Snapshot price: $0.6036

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 20
Form 4
+96.00%
1.44K
—
—
2.94K
Jan 3
Form 4
∞
37.5K
$0.19
$7,016.25
37.5K
Jun 7
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Dec 2
Form 4
—
0
—
—
0
Jul 14
Form 3
—
0
—
—
0
No matching records found